
|Articles|April 16, 2007
Latebreakers: Combo diabetes drug gets FDA nod
The FDA has approved the combination of sitagliptin (Januvia, Merck) and metformin for the treatment of Type 2 diabetes.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Study Identifies Patients at Risk for Severe COVID-19 Post-Vaccination
2
Zepbound Lowers Health Care Costs in Older Adults With Obesity
3
Measles Resurgence Exposes US Vaccine Policy Risks, Experts Warn
4
Ixekizumab, Tirzepatide Maintains Efficacy in Psoriatic Disease
5






































